A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer
2015; Springer Science+Business Media; Volume: 152; Issue: 1 Linguagem: Inglês
10.1007/s10549-015-3453-9
ISSN1573-7217
AutoresDaniele Generali, Sergio Venturini, Carla Rognoni, Oriana Ciani, Lajos Pusztai, Sherene Loi, Guy Jérusalem, Alberto Bottini, Rosanna Tarricone,
Tópico(s)Advanced Breast Cancer Therapies
Referência(s)